Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Compounding may occur in a 503A pharmacy for a named patient or in a 503B outsourcing facility for office use
ARA-290 activates the innate repair receptor, which is selectively upregulated in damaged tissue providing injury-targeted anti-apoptotic and anti-inflammatory effects
This angiogenic activity is believed to underlie a substantial part of the compounds regenerative behaviour in laboratory work, since improved vascular supply supports the delivery of nutrients to repairing tissue
Analytical testing for this batch was performed by Liquilabs s.r.o
US$ 22.95
US$ 29.09
US$ 21.94
US$ 27.94
US$ 29.14
US$ 20.99
![Fragment [1-25]-Tirzepatide](https://www.daicelpharmastandards.com/wp-content/uploads/2025/04/dcti-d-571.png)
US$ 26.82
US$ 23.17
US$ 20.74
US$ 28.83
US$ 24.00
US$ 25.57
